1-3 of 3
Robert Kreitman, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Negative Minimal Residual Disease Associated with Extended Response to Moxetumomab Pasudotox in Patients with Relapsed/Refractory Hairy Cell Leukemia: Long-Term Follow-up of Bone Marrow Immunohistochemistry Analyses from a Phase 1 Study

Robert Kreitman, MD, Martin S. Tallman, MD, Tadeusz Robak, MD PhD, Steven Coutre, MD, Shannon Marshall, PhD, Jie Yang, PhD, Ira Pastan, MD, Nai Shun (Nancy) Yao, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2765.
https://doi.org/10.1182/blood.V130.Suppl_1.2765.2765
Published: 2017
Journal Articles

Molecular Characteristic of Variant and Classic Hairy Cell Leukemia.

Evgeny Arons, PhD, Tara Suntum, Joel Sunshine, Anna Orthwein, Inger Margulies, Maryalice Stetler-Stevenson, MD, PhD, Robert Kreitman, MD
Journal: Blood
Blood (2008) 112 (11): 1063.
https://doi.org/10.1182/blood.V112.11.1063.1063
Published: 2008
Journal Articles

IRTA2 Protein on Lymphoma Cell Lines and Hairy Cell Leukemia Cells Detected by Novel Monoclonal Antibodies.

Tomoko Ise, PhD, Satoshi Nagata, PhD, Hiroshi Maeda, PhD, Robert Kreitman, MD, Maryalice Stetler-Stevenson, PhD, Ira Pastan, MD
Journal: Blood
Blood (2004) 104 (11): 1101.
https://doi.org/10.1182/blood.V104.11.1101.1101
Published: 2004